Tucker William A, Birt Mitchell C, Heddings Archie A, Horton Greg A
Orthopedics. 2020 Jul 1;43(4):221-227. doi: 10.3928/01477447-20200428-06. Epub 2020 May 7.
The association of nonsteroidal anti-inflammatory drugs (NSAIDs) with non-union in long bone fractures has been controversial. The purpose of this study was to evaluate whether NSAID exposure results in increased risk of non-union in operatively treated long bone fractures. The authors used International Classification of Diseases and Current Procedural Terminology codes to identify patients under a single-payer private insurance with operatively treated humeral shaft, tibial shaft, and subtrochanteric femur fractures from a large database. Patients were divided into cohorts based on NSAID use in the immediate postoperative period, and nonunion rates were compared. A cost analysis and a multivariate analysis were performed. Between 2007 and 2016, a total of 5310 tibial shaft, 3947 humeral shaft, and 8432 subtrochanteric femur fractures underwent operative fixation. Patients used NSAIDs in the first 90 days postoperatively in 900 tibial shaft, 694 humeral shaft, and 967 subtrochanteric femur fractures. In these patients, nonunion rates were 18.8%, 17.4%, and 10.4%, respectively. When no NSAIDs were used, the rates were 11.4%, 10.1%, and 4.6% for each fracture type, respectively (P<.05). Among patients taking NSAIDs, subtrochanteric femur fractures had a 2.4 times higher risk of nonunion and humeral shaft and tibial shaft fractures both had a 1.7 times higher risk of nonunion (P<.05). Multivariate analysis showed NSAID use to be an independent risk factor in all 3 types. Cost analysis showed a great increase in economic burden (P<.05). This study indicated that NSAID exposure was associated with fracture nonunion. [Orthopedics. 2020;43(4):221-227.].
非甾体抗炎药(NSAIDs)与长骨骨折不愈合之间的关联一直存在争议。本研究的目的是评估NSAIDs暴露是否会增加手术治疗的长骨骨折不愈合的风险。作者使用国际疾病分类和当前手术操作术语代码,从一个大型数据库中识别出由单一支付方私人保险承保的、接受过肱骨干、胫骨干和股骨转子下骨折手术治疗的患者。根据术后即刻使用NSAIDs的情况将患者分为不同队列,并比较不愈合率。进行了成本分析和多变量分析。2007年至2016年期间,共有5310例胫骨干骨折、3947例肱骨干骨折和8432例股骨转子下骨折接受了手术固定。术后90天内使用NSAIDs的患者中,胫骨干骨折900例、肱骨干骨折694例、股骨转子下骨折967例。在这些患者中,不愈合率分别为18.8%、17.4%和10.4%。未使用NSAIDs时,每种骨折类型的不愈合率分别为11.4%、10.1%和4.6%(P<0.05)。在使用NSAIDs的患者中,股骨转子下骨折不愈合的风险高2.4倍,肱骨干和胫骨干骨折不愈合的风险均高1.7倍(P<0.05)。多变量分析显示,使用NSAIDs是所有3种类型骨折不愈合的独立危险因素。成本分析显示经济负担大幅增加(P<0.05)。本研究表明,NSAIDs暴露与骨折不愈合有关。[《骨科》。2020年;43(4):221 - 227。]